Waller C A, Braun M, Schirrmacher V
Clin Exp Metastasis. 1986 Apr-Jun;4(2):73-89. doi: 10.1007/BF00119075.
Various murine tumour sublines which differed considerably in their in vivo metastatic capacity were tested in vitro for their ability to invade normal tissue. For this purpose we developed two quantitative tests, a Boyden chamber endothelial cell invasion assay and a brain tissue microsphere invasion assay. The invasion of [75Se]methionine-prelabelled tumour cells into the normal tissues was followed by measuring the percentage of tumour-associated label in the brain microspheres or the endothelial monolayers after 12-48 h of co-cultivation. Clear and comparable differences existed in both assays between the amount of radiolabel found in the normal tissues after a co-cultivation with the different tumour lines. In three of the four tumour lines invasiveness correlated with metastatic capacity. The fourth line, a plastic adherent variant, was highly invasive but low metastatic. The ability of tumour cells to invade normal tissue, therefore, while necessary for the generation of metastases, is not in itself sufficient. Since both assays are independent of time-consuming histological sectioning and staining and allow a quantitative determination of invasive capacity of tumour cells grown as single cell suspensions they appear well suited for experimental manipulation and for screening of anti-invasive drugs.
对多种在体内转移能力差异很大的小鼠肿瘤亚系进行体外侵袭正常组织能力的测试。为此,我们开发了两种定量检测方法,一种是博伊登小室内皮细胞侵袭试验,另一种是脑组织微球侵袭试验。将用[75Se]蛋氨酸预标记的肿瘤细胞与正常组织共同培养12 - 48小时后,通过测量脑微球或内皮单层中与肿瘤相关的标记物百分比,追踪肿瘤细胞侵入正常组织的情况。在两种检测方法中,与不同肿瘤系共同培养后,在正常组织中发现的放射性标记量均存在明显且可比的差异。在四个肿瘤系中的三个,侵袭性与转移能力相关。第四个系是一种贴壁生长的变体,侵袭性高但转移性低。因此,肿瘤细胞侵袭正常组织的能力虽然是发生转移所必需的,但仅靠其自身并不足够。由于这两种检测方法都无需耗时的组织学切片和染色,并且能够对作为单细胞悬液生长的肿瘤细胞的侵袭能力进行定量测定,所以它们似乎非常适合用于实验操作和抗侵袭药物的筛选。